Infinity Pharmaceuticals Announces the Initiation of Two Clinical Trials Evaluating IPI-549 in Novel Triple Combination Therapies for the Treatment of Solid Tumors

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Infinitum Copper Corp. Announces Completion of Share Consolidation and Update on Private Placement
Infinitum Copper Corp. Announces Proposed Share Consolidation
Infinitum Copper Amends the Terms of the C$450,000 Private Placement
Infinitum Copper Announces C$450,000 Private Placement
Infinitum to Use AI at Hot Breccia Copper Project in Arizona
Market Update - Infintium Copper Applies for Mining Permits and Receives Results of Metallurgical Test Work
Infinitum Copper ZTEM Survey Identifies Priority Drill Targets at Hot Breccia in Arizona
INFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.